Aflibercept: osteonecrosis of the jaw: Watch out for high-risk situations.
出版信息
Prescrire Int. 2016 Nov;25(176):271.
PMID:30730125
Abstract
摘要
相似文献
1
Aflibercept: osteonecrosis of the jaw: Watch out for high-risk situations.
Prescrire Int. 2016 Nov;25(176):271.
2
[Not Available].
Rev Stomatol Chir Maxillofac Chir Orale. 2016 Nov;117(5):363-365. doi: 10.1016/j.revsto.2016.05.002. Epub 2016 Jun 27.
3
Avascular osteonecrosis of the jaw as a side effect of bisphosphonate treatment.
Onkologie. 2010;33(6):288-9. doi: 10.1159/000313684. Epub 2010 May 14.
4
Diagnosis and Staging of Medication-Related Osteonecrosis of the Jaw.
Oral Maxillofac Surg Clin North Am. 2015 Nov;27(4):479-87. doi: 10.1016/j.coms.2015.06.008. Epub 2015 Aug 18.
5
Osteonecrosis of the jaw and the use of antiangiogenic agents: just an association?
Oncologist. 2008 Dec;13(12):1314; author reply 1315. doi: 10.1634/theoncologist.2008-0206. Epub 2008 Dec 16.
6
The Frequency of Medication-related Osteonecrosis of the Jaw and its Associated Risk Factors.
Oral Maxillofac Surg Clin North Am. 2015 Nov;27(4):509-16. doi: 10.1016/j.coms.2015.06.003. Epub 2015 Sep 9.
7
Incongruities in the AAOMS position paper: medication-related osteonecrosis of the jaw--2014 update.
J Oral Maxillofac Surg. 2014 Dec;72(12):2381. doi: 10.1016/j.joms.2014.07.045. Epub 2014 Oct 12.
8
In reply.
J Oral Maxillofac Surg. 2014 Dec;72(12):2381-2. doi: 10.1016/j.joms.2014.08.017. Epub 2014 Oct 7.
9
American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update and CTX.
J Oral Maxillofac Surg. 2015 Mar;73(3):377. doi: 10.1016/j.joms.2014.10.035.
10
Reply: To PMID 25234529.
J Oral Maxillofac Surg. 2015 Jul;73(7):1239-40. doi: 10.1016/j.joms.2015.03.060. Epub 2015 Apr 24.
Zotero 插件